Related Experiment Video
Updated: Jan 25, 2026

RNA Interference-based Investigation of the Function of Heat Shock Protein 27 during Corneal Epithelial Wound Healing
Published on: September 27, 2016
Functional characterization of 27 CYP3A4 protein variants to metabolize regorafenib in vitro
Ying-Hui Li1, Qian-Meng Lin1, Ni-Hong Pang1
1Department of Pharmacology, School of Pharmacy, Wenzhou Medical University, Wenzhou, China.
Aim:
Regorafenib is a tyrosine kinase inhibitor that is mainly metabolized by CYP3A4. The genetic polymorphism of CYP3A4 would contribute to differences in metabolism of regorafenib. Previously, we had discovered several novel CYP3A4 variants. However, the catalytic characteristics of these 27 CYP3A4 variants on oxidizing regorafenib have not being determined. The purpose of this study was to investigate the catalytic characteristics of 27 CYP3A4 protein variants on the oxidative metabolism of regorafenib in vitro.
Method:
Wild-type CYP3A4.1 or other variants was incubated with 0.5-20 μmol/L regorafenib for 30 minutes. After sample processing, regorafenib-N-oxide, a primary metabolite, was detected by ultra-performance liquid chromatography-tandem mass spectrometry system.
Result:
CYP3A4.20 had no detectable enzyme activity compared with wild-type CYP3A4.1; five variants (CYP3A4.5, .16, .19, .24, .29) exhibited similar clearance value with CYP3A4.1; four variants (CYP3A4.14, .15, .28, .31) displayed increased enzymatic activities, while remaining variants showed markedly decreased intrinsic clearance values.
Conclusion:
This study is the first to investigate the function of 27 CYP3A4 protein variants on the metabolism of regorafenib in vitro, and it may provide some valuable information for further research in clinic.
Insights
This study characterized 27 CYP3A4 variants’ impact on regorafenib metabolism. Four variants showed increased activity, one showed none, and others had decreased or similar activity compared to wild-type CYP3A4.1.
Area of Science:
- Pharmacogenomics
- Drug Metabolism
- Enzyme Kinetics
Background:
- Regorafenib, a tyrosine kinase inhibitor, is primarily metabolized by CYP3A4.
- Genetic variations in CYP3A4 can significantly alter regorafenib metabolism.
- Understanding these variations is crucial for personalized medicine and optimizing regorafenib therapy.
Purpose of the Study:
- To investigate the in vitro catalytic characteristics of 27 novel CYP3A4 protein variants on the oxidative metabolism of regorafenib.
- To determine how genetic polymorphisms in CYP3A4 affect regorafenib clearance.
- To provide foundational data for clinical studies on regorafenib pharmacogenetics.
Main Methods:
- Incubation of wild-type CYP3A4.1 and 27 variants with varying concentrations of regorafenib (0.5–20 μmol/L) for 30 minutes.
- Detection and quantification of regorafenib-N-oxide, a key metabolite, using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS).
- Determination of intrinsic clearance values for each CYP3A4 variant.
Main Results:
- CYP3A4.20 exhibited no detectable enzyme activity.
- Five variants (CYP3A4.5, .16, .19, .24, .29) showed clearance values comparable to wild-type CYP3A4.1.
- Four variants (CYP3A4.14, .15, .28, .31) demonstrated significantly increased enzymatic activity, while the remaining variants displayed markedly decreased intrinsic clearance.
Conclusions:
- This study provides the first comprehensive in vitro functional characterization of 27 CYP3A4 variants concerning regorafenib metabolism.
- The identified variants exhibit diverse catalytic activities, impacting regorafenib clearance.
- These findings may inform future clinical research and guide personalized regorafenib treatment strategies.
Related Concept Videos
Histone Variants at the Centromere
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Structural Protein Function
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to...
Structural Protein Function
Mechanical Protein Functions
What is Metabolism?

